Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections

Introduction

GlobalData’s new report, “Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections” provides key market data on the Russian Federation Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within four market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within four market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the four market categories.
- Global corporate-level profiles of key companies operating within the Russian Federation Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline plc, Baxter International Inc., Boehringer Ingelheim GmbH, Medtronic, Inc., CareFusion Corporation, Fresenius Kabi AG and others.

Highlights

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Russian Federation Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Report Highlights
GlaxoSmithKline plc
Baxter International Inc.
Boehringer Ingelheim GmbH
Medtronic, Inc.
CareFusion Corporation
Fresenius Kabi AG
AstraZeneca PLC
Hospira, Inc.
B. Braun Melsungen AG
Terumo Corporation
Smiths Medical
Codman & Shurtleff, Inc.
Teleflex Incorporated
Consort Medical plc
INJEX - Equidyne Systems
Antares Pharma, Inc.
Bioject Medical Technologies Inc.
Edwards Lifesciences Corporation
Becton, Dickinson and Company
[Studien Infos ausblenden]

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What is This Report About? 11
3 Drug Delivery Devices In Russian Federation 12
3.1 Drug Delivery Devices, Market Segmentation 12
3.2 Drug Delivery Devices, Russian Federation, Overall Revenue ($m), 2003-2017 13
3.3 Drug Delivery Devices Market, Russian Federation, Revenue Mix ($m), 2010 15
3.4 Drug Delivery Devices Market, Russian Federation, Category Contribution (%), 2010 16
3.5 Drug Delivery Devices, Russian Federation, Category Volume (Units), 2003-2017 22
3.6 Drug Delivery Devices, Russian Federation, Company Share (2009-2010) 27
4 Central Venous Catheters In Russian Federation 29
4.1 Central Venous Cath Central Venous Catheters, Market Segmentation 29
4.2 Central Venous Catheters Market, Russian Federation, Revenue Mix ($m), 2010 30
4.3 Central Venous Catheters Market, Russian Federation, Segment Contribution (%), 2010 31
4.4 Central Venous Catheters Overall Revenue (2003-2017) 32
4.5 Central Venous Catheters Overall Volume (2003-2017) 36
4.6 Central Venous Catheters Average Price (2003-2017) 40
4.7 Central Venous Catheters Distribution Share (2009-2010) 41
4.8 Central Venous Catheters, Russian Federation, Company Share (2009-2010) 42
5 Infusion Systems In Russian Federation 44
5.1 Infusion Systems, Market Segmentation 44
5.2 Infusion Systems Market, Russian Federation, Revenue Mix ($m), 2010 45
5.3 Infusion Systems Market, Russian Federation, Segment Contribution (%), 2010 46
5.4 Infusion Systems Overall Revenue (2003-2017) 47
5.4.1 Syringe Pumps Revenue (2003-2017) 51
5.4.2 Ambulatory Infusion Pumps Revenue (2003-2017) 55
5.5 Infusion Systems Overall Volume (2003-2017) 59
5.5.1 Syringe Pumps Volume (2003-2017) 63
5.5.2 Ambulatory Infusion Pumps Volume (2003-2017) 67
5.6 Infusion Systems Average Price (2003-2017) 71
5.7 Infusion Systems Distribution Share (2009-2010) 72
5.8 Infusion Systems, Russian Federation, Company Share (2009-2010) 73
6 Metered Dose Inhaler Devices In Russian Federation 75
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 75
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 77
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 79
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 80
6.5 Metered Dose Inhaler Devices, Russian Federation, Company Share (2009-2010) 81
7 Needle Free Injections In Russian Federation 83
7.1 Needle Free Injections Overall Revenue (2003-2017) 83
7.2 Needle Free Injections Overall Volume (2003-2017) 85
7.3 Needle Free Injections Average Price (2003-2017) 87
7.4 Needle Free Injections Distribution Share (2009-2010) 88
7.5 Needle Free Injections, Russian Federation, Company Share (2009-2010) 89
8 Overview of Key Companies in Russian Federation Drug Delivery Devices Market 90
8.1 GlaxoSmithKline plc 90
8.1.1 Company Overview 90
8.1.2 Share in the Russian Federation Drug Delivery Devices Market 90
8.2 Baxter International Inc. 91
8.2.1 Company Overview 91
8.2.2 Share in the Russian Federation Drug Delivery Devices Market 91
8.3 Boehringer Ingelheim GmbH 92
8.3.1 Company Overview 92
8.3.2 Share in the Russian Federation Drug Delivery Devices Market 92
8.4 Medtronic, Inc. 93
8.4.1 Company Overview 93
8.4.2 Share in the Russian Federation Drug Delivery Devices Market 93
8.5 CareFusion Corporation 94
8.5.1 Company Overview 94
8.5.2 Share in the Russian Federation Drug Delivery Devices Market 94
8.6 Fresenius Kabi AG 95
8.6.1 Company Overview 95
8.6.2 Share in the Russian Federation Drug Delivery Devices Market 95
8.7 AstraZeneca PLC 96
8.7.1 Company Overview 96
8.8 Hospira, Inc. 96
8.8.1 Company Overview 96
8.9 B. Braun Melsungen AG 96
8.9.1 Company Overview 96
8.10 Terumo Corporation 97
8.10.1 Company Overview 97
8.11 Smiths Medical 97
8.11.1 Company Overview 97
8.12 Codman & Shurtleff, Inc. 97
8.12.1 Company Overview 97
8.13 Teleflex Incorporated 98
8.13.1 Company Overview 98
8.14 Consort Medical plc 98
8.14.1 Company Overview 98
8.15 INJEX - Equidyne Systems 98
8.15.1 Company Overview 98
8.16 Antares Pharma, Inc. 99
8.16.1 Company Overview 99
8.17 Bioject Medical Technologies Inc. 99
8.17.1 Company Overview 99
8.18 Edwards Lifesciences Corporation 100
8.18.1 Company Overview 100
8.19 Becton, Dickinson and Company 100
8.19.1 Company Overview 100
9 Drug Delivery Devices Market Pipeline Products 101
10 Appendix 106
10.1 Definitions of Markets Covered in the Report 107
10.1.1 Drug Delivery Devices 107
10.2 Research Methodology 110
10.3 Secondary Research 110
10.4 Primary Research 111
10.5 Models 111
10.6 Forecasts 112
10.7 Expert Panels 112
10.8 GlobalData Consulting 112
10.9 Currency Conversion 112
10.10 Contact Us 113
10.11 Disclaimer 113
[Inhaltsverzeichnis ausblenden]

1.1 List of Tables
Table 1: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), 2003-2017 14
Table 2: Drug Delivery Devices Market, Russian Federation, Category Contribution (%), 2010 16
Table 3: Drug Delivery Devices, Russian Federation Cross-Category Analysis, 2003-2017 17
Table 4: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), Historic, 2003-2010 19
Table 5: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), Forecast, 2010-2017 21
Table 6: Drug Delivery Devices, Russian Federation, Category Volume (Units), 2003-2017 22
Table 7: Drug Delivery Devices, Russian Federation, Category Volume (Units), Historic, 2003-2010 24
Table 8: Drug Delivery Devices, Russian Federation, Category Volume (Units), Forecast, 2010-2017 26
Table 9: Drug Delivery Devices, Russian Federation, Company Share by Revenue ($m), 2009-2010 28
Table 10: Central Venous Catheters Market, Russian Federation, Segment Contribution (%), 2010 31
Table 11: Central Venous Catheters, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 33
Table 12: Central Venous Catheters, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 35
Table 13: Central Venous Catheters, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 37
Table 14: Central Venous Catheters, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 39
Table 15: Central Venous Catheters, Russian Federation, Average Price ($), Historic, 2003-2010 40
Table 16: Central Venous Catheters, Russian Federation, Average Price ($), Forecast, 2010-2017 40
Table 17: Central Venous Catheters, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 41
Table 18: Central Venous Catheters, Russian Federation, Company Share by Revenue ($m), 2009-2010 43
Table 19: Infusion Systems Market, Russian Federation, Segment Contribution (%), 2010 46
Table 20: Infusion Systems, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 48
Table 21: Infusion Systems, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 50
Table 22: Syringe Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Historic, 2003-2010 52
Table 23: Syringe Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 54
Table 24: Ambulatory Infusion Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Historic, 2003-2010 56
Table 25: Ambulatory Infusion Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 58
Table 26: Infusion Systems, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 60
Table 27: Infusion Systems, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 62
Table 28: Syringe Pumps, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 64
Table 29: Syringe Pumps, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 66
Table 30: Ambulatory Infusion Pumps, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 68
Table 31: Ambulatory Infusion Pumps, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 70
Table 32: Infusion Systems, Russian Federation, Average Price ($), Historic, 2003-2010 71
Table 33: Infusion Systems, Russian Federation, Average Price ($), Forecast, 2010-2017 71
Table 34: Infusion Systems, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 72
Table 35: Infusion Systems, Russian Federation, Company Share by Revenue ($m), 2009-2010 74
Table 36: Metered Dose Inhaler Devices, Russian Federation, Revenue ($m), Historic, 2003-2010 75
Table 37: Metered Dose Inhaler Devices, Russian Federation, Revenue ($m), Forecast, 2010-2017 76
Table 38: Metered Dose Inhaler Devices, Russian Federation, Volume (Units), Historic, 2003-2010 77
Table 39: Metered Dose Inhaler Devices, Russian Federation, Volume (Units), Forecast, 2010-2017 78
Table 40: Metered Dose Inhaler Devices, Russian Federation, Average Price ($), Historic, 2003-2010 79
Table 41: Metered Dose Inhaler Devices, Russian Federation, Average Price ($), Forecast, 2010-2017 79
Table 42: Metered Dose Inhaler Devices, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 80
Table 43: Metered Dose Inhaler Devices, Russian Federation, Company Share by Revenue ($m), 2009-2010 82
Table 44: Needle Free Injections, Russian Federation, Revenue ($m), Historic, 2003-2010 83
Table 45: Needle Free Injections, Russian Federation, Revenue ($m), Forecast, 2010-2017 84
Table 46: Needle Free Injections, Russian Federation, Volume (Units), Historic, 2003-2010 85
Table 47: Needle Free Injections, Russian Federation, Volume (Units), Forecast, 2010-2017 86
Table 48: Needle Free Injections, Russian Federation, Average Price ($), Historic, 2003-2010 87
Table 49: Needle Free Injections, Russian Federation, Average Price ($), Forecast, 2010-2017 87
Table 50: Needle Free Injections, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 88
Table 51: Needle Free Injections, Russian Federation, Company Share by Revenue ($m), 2009-2010 89
Table 52: Drug Delivery Devices Market Pipeline Products 101
Table 53: USD to Local Currency, Russian Federation, Average Actual Rate 2003-2010 112
1.2 List of Figures
Figure 1: Drug Delivery Devices, Market Segmentation 12
Figure 2: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), 2003-2017 13
Figure 3: Drug Delivery Devices Market, Russian Federation, Revenue Mix ($m), 2010 15
Figure 4: Drug Delivery Devices Market, Russian Federation, Category Contribution (%), 2010 16
Figure 5: Drug Delivery Devices, Russian Federation, Cross-Category Analysis, 2003-2017 17
Figure 6: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), Historic, 2003-2010 18
Figure 7: Drug Delivery Devices, Russian Federation, Overall Revenue ($m), Forecast, 2010-2017 20
Figure 8: Drug Delivery Devices, Russian Federation, Category Volume (Units), 2003-2017 22
Figure 9: Drug Delivery Devices, Russian Federation, Category Volume (Units), Historic, 2003-2010 23
Figure 10: Drug Delivery Devices, Russian Federation, Category Volume (Units), Forecast, 2010-2017 25
Figure 11: Drug Delivery Devices, Russian Federation, Company Share (%), 2010 27
Figure 12: Central Venous Catheters, Market Segmentation 29
Figure 13: Central Venous Catheters Market, Russian Federation, Revenue Mix ($m), 2010 30
Figure 14: Central Venous Catheters Market, Russian Federation, Segment Contribution (%), 2010 31
Figure 15: Central Venous Catheters, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 32
Figure 16: Central Venous Catheters, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 34
Figure 17: Central Venous Catheters, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 36
Figure 18: Central Venous Catheters, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 38
Figure 19: Central Venous Catheters, Russian Federation, Company Share (%), 2010 42
Figure 20: Infusion Systems, Market Segmentation 44
Figure 21: Infusion Systems Market, Russian Federation, Revenue Mix ($m), 2010 45
Figure 22: Infusion Systems Market, Russian Federation, Segment Contribution (%), 2010 46
Figure 23: Infusion Systems, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 47
Figure 24: Infusion Systems, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 49
Figure 25: Syringe Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Historic, 2003-2010 51
Figure 26: Syringe Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 53
Figure 27: Ambulatory Infusion Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Historic, 2003-2010 55
Figure 28: Ambulatory Infusion Pumps, Russian Federation, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 57
Figure 29: Infusion Systems, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 59
Figure 30: Infusion Systems, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 61
Figure 31: Syringe Pumps, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 63
Figure 32: Syringe Pumps, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 65
Figure 33: Ambulatory Infusion Pumps, Russian Federation, Volume (Units) by Sub-Segment, Historic, 2003-2010 67
Figure 34: Ambulatory Infusion Pumps, Russian Federation, Volume (Units) by Sub-Segment, Forecast, 2010-2017 69
Figure 35: Infusion Systems, Russian Federation, Company Share (%), 2010 73
Figure 36: Metered Dose Inhaler Devices, Russian Federation, Revenue ($m), Historic, 2003-2010 75
Figure 37: Metered Dose Inhaler Devices, Russian Federation, Revenue ($m), Forecast, 2010-2017 76
Figure 38: Metered Dose Inhaler Devices, Russian Federation, Volume (Units), Historic, 2003-2010 77
Figure 39: Metered Dose Inhaler Devices, Russian Federation, Volume (Units), Forecast, 2010-2017 78
Figure 40: Metered Dose Inhaler Devices, Russian Federation, Company Share (%), 2010 81
Figure 41: Needle Free Injections, Russian Federation, Revenue ($m), Historic, 2003-2010 83
Figure 42: Needle Free Injections, Russian Federation, Revenue ($m), Forecast, 2010-2017 84
Figure 43: Needle Free Injections, Russian Federation, Volume (Units), Historic, 2003-2010 85
Figure 44: Needle Free Injections, Russian Federation, Volume (Units), Forecast, 2010-2017 86
Figure 45: Needle Free Injections, Russian Federation, Company Share (%), 2010 89
Figure 46: GlaxoSmithKline plc, Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 90
Figure 47: Baxter International Inc., Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 91
Figure 48: Boehringer Ingelheim GmbH, Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 92
Figure 49: Medtronic, Inc., Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 93
Figure 50: CareFusion Corporation, Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 94
Figure 51: Fresenius Kabi AG, Company Share (%),Russian Federation Drug Delivery Devices Market, 2010 95
[Tabellenverzeichnis ausblenden]